Developmental and stem cell biology's bright future.
Journal
Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066
Informations de publication
Date de publication:
20 Jun 2024
20 Jun 2024
Historique:
received:
20
05
2024
revised:
20
05
2024
accepted:
20
05
2024
medline:
22
6
2024
pubmed:
22
6
2024
entrez:
21
6
2024
Statut:
ppublish
Résumé
The next 50 years of developmental biology will illuminate exciting new discoveries but are also poised to provide solutions to important problems society faces. Ten scientists whose work intersects with developmental biology in various capacities tell us about their vision for the future.
Identifiants
pubmed: 38906097
pii: S0092-8674(24)00581-6
doi: 10.1016/j.cell.2024.05.037
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3224-3228Informations de copyright
Copyright © 2024. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Declaration of interests J.L. has filed patents related to printing vascularized human tissues and organs from stem cell-derived multicellular building blocks. She is a member of the scientific advisory board of Trestle Biotherapeutics, Inc. (a startup company). Trestle has also licensed IP on kidney bioprinting from Harvard, in which the author is listed as an inventor. M.S. has filed patents for reducing aneuploidy in eggs. J.H.H. was granted (through Yeda–Weizmann Institute of Science) patents relevant to the findings and technologies discussed herein (naive and naive-like pluripotency and mouse and human structure-complete embryo models [SEMs]). J.H.H. is a co-founder and chief scientific advisor of Renewal Bio, which has licensed technologies mentioned above. M.Z.G. is an inventor on patents of stem cell-derived models of human and mouse embryos. S.M. is a founder and supervisory and scientific board member of HeartBeat.bio, an IMBA spin-off, based on submitted cardioid (2020) and multi-chamber cardioid (2022) patent applications.